1887

Abstract

Understanding the mechanisms of augmented bacterial pathogenicity in post-viral infections is the first step in the development of an effective therapy. This study assessed the effect of human coronavirus NL63 (HCoV-NL63) on the adherence of bacterial pathogens associated with respiratory tract illnesses. It was shown that HCoV-NL63 infection resulted in an increased adherence of to virus-infected cell lines and fully differentiated primary human airway epithelium cultures. The enhanced binding of bacteria correlated with an increased expression level of the platelet-activating factor receptor (PAF-R), but detailed evaluation of the bacterium–PAF-R interaction revealed a limited relevance of this process.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.028381-0
2011-06-01
2020-09-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/6/1358.html?itemId=/content/journal/jgv/10.1099/vir.0.028381-0&mimeType=html&fmt=ahah

References

  1. Abrahams A., Hallows N., French H. . ( 1919; A further investigation into influenzo-pneumococcal and influenzo-streptococcal septicaemia: epidemic influenzal pneumonia of highly fatal type and its relation to puruleng bronchitis. Lancet 193:1–11 [CrossRef]
    [Google Scholar]
  2. Avadhanula V., Rodriguez C. A., Devincenzo J. P., Wang Y., Webby R. J., Ulett G. C., Adderson E. E. 2006; Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol 80:1629–1636 [CrossRef][PubMed]
    [Google Scholar]
  3. Avadhanula V., Wang Y., Portner A., Adderson E. 2007; Nontypeable Haemophilus influenzae and Streptococcus pneumoniae bind respiratory syncytial virus glycoprotein. J Med Microbiol 56:1133–1137 [CrossRef][PubMed]
    [Google Scholar]
  4. Barletta E., Mugnai G., Ruggieri S. 2002; Platelet activating factor inhibits the expression of matrix metalloproteinases and affects invasiveness and differentiation in a system of human neuroblastoma clones. Biol Chem 383:189–197 [CrossRef][PubMed]
    [Google Scholar]
  5. Bastien N., Robinson J. L., Tse A., Lee B. E., Hart L., Li Y. 2005; Human coronavirus NL-63 infections in children: a 1-year study. J Clin Microbiol 43:4567–4573 [CrossRef][PubMed]
    [Google Scholar]
  6. Brook I. 2002; Anaerobic infections in children. Microbes Infect 4:1271–1280 [CrossRef][PubMed]
    [Google Scholar]
  7. Brook I., Frazier E. H. 1993; Aerobic and anaerobic microbiology of empyema. A retrospective review in two military hospitals. Chest 103:1502–1507 [CrossRef][PubMed]
    [Google Scholar]
  8. Carlisle M. D., Srikantha R. N., Brogden K. A. 2009; Degradation of human α- and β-defensins by culture supernatants of Porphyromonas gingivalis strain 381. J Innate Immun 1:118–122 [CrossRef][PubMed]
    [Google Scholar]
  9. Chiu S. S., Chan K. H., Chu K. W., Kwan S. W., Guan Y., Poon L. L., Peiris J. S. 2005; Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin Infect Dis 40:1721–1729 [CrossRef][PubMed]
    [Google Scholar]
  10. Cundell D. R., Gerard N. P., Gerard C., Idanpaan-Heikkila I., Tuomanen E. I. 1995; Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377:435–438 [CrossRef][PubMed]
    [Google Scholar]
  11. Dijkman R., Jebbink M. F., El Idrissi N. B., Pyrc K., Müller M. A., Kuijpers T. W., Zaaijer H. L., van der Hoek L. 2008; Human coronavirus NL63 and 229E seroconversion in children. J Clin Microbiol 46:2368–2373 [CrossRef][PubMed]
    [Google Scholar]
  12. Duttweiler L., Nadal D., Frey B. 2004; Pulmonary and systemic bacterial co-infections in severe RSV bronchiolitis. Arch Dis Child 89:1155–1157 [CrossRef][PubMed]
    [Google Scholar]
  13. Finegold S. M. 1991; Aspiration pneumonia. Rev Infect Dis 13:Suppl. 9S737–S742[PubMed] [CrossRef]
    [Google Scholar]
  14. Fouchier R. A., Hartwig N. G., Bestebroer T. M., Niemeyer B., de Jong J. C., Simon J. H., Osterhaus A. D. 2004; A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci U S A 101:6212–6216 [CrossRef][PubMed]
    [Google Scholar]
  15. Golda A., Pyrc K. 2008; Recent antiviral strategies against human coronavirus-related respiratory illnesses. Curr Opin Pulm Med 14:248–253 [CrossRef][PubMed]
    [Google Scholar]
  16. Håkansson A., Kidd A., Wadell G., Sabharwal H., Svanborg C. 1994; Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae . Infect Immun 62:2707–2714[PubMed]
    [Google Scholar]
  17. Hament J. M., Kimpen J. L., Fleer A., Wolfs T. F. 1999; Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol Med Microbiol 26:189–195 [CrossRef][PubMed]
    [Google Scholar]
  18. Hament J. M., Aerts P. C., Fleer A., Van Dijk H., Harmsen T., Kimpen J. L., Wolfs T. F. 2004; Enhanced adherence of Streptococcus pneumoniae to human epithelial cells infected with respiratory syncytial virus. Pediatr Res 55:972–978 [CrossRef][PubMed]
    [Google Scholar]
  19. Hament J. M., Aerts P. C., Fleer A., van Dijk H., Harmsen T., Kimpen J. L., Wolfs T. F. 2005; Direct binding of respiratory syncytial virus to pneumococci: a phenomenon that enhances both pneumococcal adherence to human epithelial cells and pneumococcal invasiveness in a murine model. Pediatr Res 58:1198–1203 [CrossRef][PubMed]
    [Google Scholar]
  20. Hofmann H., Pyrc K., van der Hoek L., Geier M., Berkhout B., Pöhlmann S. 2005; Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A 102:7988–7993 [CrossRef][PubMed]
    [Google Scholar]
  21. Ishizuka S., Yamaya M., Suzuki T., Takahashi H., Ida S., Sasaki T., Inoue D., Sekizawa K., Nishimura H., Sasaki H. 2003; Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells. J Infect Dis 188:1928–1939 [CrossRef][PubMed]
    [Google Scholar]
  22. Kaiser L., Regamey N., Roiha H., Deffernez C., Frey U. 2005; Human coronavirus NL63 associated with lower respiratory tract symptoms in early life. Pediatr Infect Dis J 24:1015–1017 [CrossRef][PubMed]
    [Google Scholar]
  23. Kneyber M. C. J., Blussé van Oud-Alblas H., van Vliet M., Uiterwaal C. S. P. M., Kimpen J. L. L., van Vught A. J. 2005; Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory tract disease. Intensive Care Med 31:680–685 [CrossRef][PubMed]
    [Google Scholar]
  24. Louria D. B., Blumenfeld H. L., Ellis J. T., Kilbourne E. D., Rogers D. E. 1959; Studies on influenza in the pandemic of 1957–1958. II. Pulmonary complications of influenza. J Clin Invest 38:213–265 [CrossRef][PubMed]
    [Google Scholar]
  25. McCullers J. A. 2006; Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 19:571–582 [CrossRef][PubMed]
    [Google Scholar]
  26. McCullers J. A., Bartmess K. C. 2003; Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae . J Infect Dis 187:1000–1009 [CrossRef][PubMed]
    [Google Scholar]
  27. McCullers J. A., Rehg J. E. 2002; Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 186:341–350 [CrossRef][PubMed]
    [Google Scholar]
  28. McCullers J. A., Iverson A. R., McKeon R., Murray P. J. 2008; The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza. Scand J Infect Dis 40:11–17 [CrossRef][PubMed]
    [Google Scholar]
  29. Muir R., Wilson G. H. 1919; Influenza and its complications. BMJ 1:3–5 [CrossRef][PubMed]
    [Google Scholar]
  30. Okamoto T., Akuta T., Tamura F., van Der Vliet A., Akaike T. 2004; Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation. Biol Chem 385:997–1006 [CrossRef][PubMed]
    [Google Scholar]
  31. Okuda K., Kimizuka R., Abe S., Kato T., Ishihara K. 2005; Involvement of periodontopathic anaerobes in aspiration pneumonia. J Periodontol 76:Suppl.2154–2160 [CrossRef][PubMed]
    [Google Scholar]
  32. Orenstein J. M., Banach B., Baker S. C. 2008; Morphogenesis of coronavirus HCoV-NL63 in cell culture: a transmission electron microscopic study. Open Infect Dis J 2:52–58 [CrossRef][PubMed]
    [Google Scholar]
  33. Passariello C., Schippa S., Conti C., Russo P., Poggiali F., Garaci E., Palamara A. T. 2006; Rhinoviruses promote internalisation of Staphylococcus aureus into non-fully permissive cultured pneumocytes. Microbes Infect 8:758–766 [CrossRef][PubMed]
    [Google Scholar]
  34. Patel J. A., Kunimoto M., Sim T. C., Garofalo R., Eliott T., Baron S., Ruuskanen O., Chonmaitree T., Ogra P. L., Schmalstieg F. 1995; Interleukin-1α mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus. Am J Respir Cell Mol Biol 13:602–609[PubMed] [CrossRef]
    [Google Scholar]
  35. Peltola V. T., McCullers J. A. 2004; Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J 23:Suppl.S87–S97 [CrossRef][PubMed]
    [Google Scholar]
  36. Peltola V. T., Murti K. G., McCullers J. A. 2005; Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis 192:249–257 [CrossRef][PubMed]
    [Google Scholar]
  37. Potempa J., Pike R. N. 2009; Corruption of innate immunity by bacterial proteases. J Innate Immun 1:70–87 [CrossRef][PubMed]
    [Google Scholar]
  38. Pyrc K., Jebbink M. F., Berkhout B., van der Hoek L. 2004; Genome structure and transcriptional regulation of human coronavirus NL63. Virol J 1:7 [CrossRef][PubMed]
    [Google Scholar]
  39. Pyrc K., Dijkman R., Deng L., Jebbink M. F., Ross H. A., Berkhout B., van der Hoek L. 2006; Mosaic structure of human coronavirus NL63, one thousand years of evolution. J Mol Biol 364:964–973 [CrossRef][PubMed]
    [Google Scholar]
  40. Pyrc K., Berkhout B., van der Hoek L. 2007a). Identification of new human coronaviruses. Expert Rev Anti Infect Ther 5:245–253 [CrossRef][PubMed]
    [Google Scholar]
  41. Pyrc K., Berkhout B., van der Hoek L. 2007b). The novel human coronaviruses NL63 and HKU1. J Virol 81:3051–3057 [CrossRef][PubMed]
    [Google Scholar]
  42. Pyrc K., Jebbink M. F., Berkhout B., van der Hoek L. 2008; Detection of new viruses by VIDISCA. Virus discovery based on cDNA-amplified fragment length polymorphism. Methods Mol Biol 454:73–89 [CrossRef][PubMed]
    [Google Scholar]
  43. Pyrc K., Sims A. C., Dijkman R., Jebbink M., Long C., Deming D., Donaldson E., Vabret A., Baric R. et al. 2010; Culturing the unculturable: human coronavirus HKU1 infects, replicates, and produces progeny virions in human ciliated airway epithelial cell cultures. J Virol 84:11255–11263 [CrossRef][PubMed]
    [Google Scholar]
  44. Radin J. N., Orihuela C. J., Murti G., Guglielmo C., Murray P. J., Tuomanen E. I. 2005; β-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae . Infect Immun 73:7827–7835 [CrossRef][PubMed]
    [Google Scholar]
  45. Randolph A. G., Reder L., Englund J. A. 2004; Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit. Pediatr Infect Dis J 23:990–994 [CrossRef][PubMed]
    [Google Scholar]
  46. Reed L. J., Muench H. 1938; A simple method of estimating fifty percent endpoints. Am J Hyg 27:493–497
    [Google Scholar]
  47. Scannapieco F. A. 1999; Role of oral bacteria in respiratory infection. J Periodontol 70:793–802 [CrossRef][PubMed]
    [Google Scholar]
  48. Schildgen O., Jebbink M. F., de Vries M., Pyrc K., Dijkman R., Simon A., Müller A., Kupfer B., van der Hoek L. 2006; Identification of cell lines permissive for human coronavirus NL63. J Virol Methods 138:207–210 [CrossRef][PubMed]
    [Google Scholar]
  49. Schreiner A. 1979; Anaerobic pulmonary infections. Scand J Infect Dis Suppl 19:77–79[PubMed]
    [Google Scholar]
  50. Sims A. C., Yount B., Burkett S. E., Baric R. S., Pickles R. J. 2006; SARS CoV replication and pathogenesis in human airway epithelial cultures. Adv Exp Med Biol 581:535–538 [CrossRef][PubMed]
    [Google Scholar]
  51. Stille W. T., Pierce W., Crawford Y. E. 1961; Multiple infections in acute respiratory illness. I. Severity of illness of naval recruits and independence of infectious agents. J Infect Dis 109:158–165[PubMed] [CrossRef]
    [Google Scholar]
  52. Stone W. J., Swift G. W. 1919; Influenza and influenzal pneumonia at Fort Riley, Kansas. JAMA 72:487–493 [CrossRef]
    [Google Scholar]
  53. Suzuki A., Okamoto M., Ohmi A., Watanabe O., Miyabayashi S., Nishimura H. 2005; Detection of human coronavirus-NL63 in children in Japan. Pediatr Infect Dis J 24:645–646 [CrossRef][PubMed]
    [Google Scholar]
  54. Terajima M., Yamaya M., Sekizawa K., Okinaga S., Suzuki T., Yamada N., Nakayama K., Ohrui T., Oshima T. et al. 1997; Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1β. Am J Physiol 273:L749–L759[PubMed]
    [Google Scholar]
  55. Thompson C. I., Barclay W. S., Zambon M. C., Pickles R. J. 2006; Infection of human airway epithelium by human and avian strains of influenza a virus. J Virol 80:8060–8068 [CrossRef][PubMed]
    [Google Scholar]
  56. Thorburn K., Harigopal S., Reddy V., Taylor N., van Saene H. K. 2006; High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax 61:611–615 [CrossRef][PubMed]
    [Google Scholar]
  57. Tong H. H., Weiser J. N., James M. A., DeMaria T. F. 2001; Effect of influenza A virus infection on nasopharyngeal colonization and otitis media induced by transparent or opaque phenotype variants of Streptococcus pneumoniae in the chinchilla model. Infect Immun 69:602–606 [CrossRef][PubMed]
    [Google Scholar]
  58. Vabret A., Mourez T., Dina J., van der Hoek L., Gouarin S., Petitjean J., Brouard J., Freymuth F. 2005; Human coronavirus NL63, France. Emerg Infect Dis 11:1225–1229[PubMed] [CrossRef]
    [Google Scholar]
  59. van der Hoek L., Pyrc K., Jebbink M. F., Vermeulen-Oost W., Berkhout R. J., Wolthers K. C., Wertheim-van Dillen P. M., Kaandorp J., Spaargaren J., Berkhout B. 2004; Identification of a new human coronavirus. Nat Med 10:368–373 [CrossRef][PubMed]
    [Google Scholar]
  60. van der Hoek L., Sure K., Ihorst G., Stang A., Pyrc K., Jebbink M. F., Petersen G., Forster J., Berkhout B., Uberla K. 2005; Croup is associated with the novel coronavirus NL63. PLoS Med 2:e240 [CrossRef][PubMed]
    [Google Scholar]
  61. van der Hoek L., Sure K., Ihorst G., Stang A., Pyrc K., Jebbink M. F., Petersen G., Forster J., Berkhout B., Uberla K. 2006; Human coronavirus NL63 infection is associated with croup. Adv Exp Med Biol 581:485–491 [CrossRef][PubMed]
    [Google Scholar]
  62. van der Sluijs K. F., van Elden L. J., Nijhuis M., Schuurman R., Florquin S., Shimizu T., Ishii S., Jansen H. M., Lutter R., van der Poll T. 2006; Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. Am J Physiol Lung Cell Mol Physiol 290:L194–L199 [CrossRef][PubMed]
    [Google Scholar]
  63. Van Ewijk B. E., Wolfs T. F., Aerts P. C., Van Kessel K. P., Fleer A., Kimpen J. L., Van der Ent C. K. 2007; RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells. Pediatr Res 61:398–403 [CrossRef][PubMed]
    [Google Scholar]
  64. Wilson C. B. P. S., Steer P. 1919; Bacteriological and pathological observations on influenza as seen in France during 1918. Br Med J 1:634–635 [CrossRef]
    [Google Scholar]
  65. Wolbach S. B. 1919; Comments on the pathology and bacteriology of fatal influenza cases, as observed at Camp Devens, Mass. John Hopkins Hosp Bull 30:104–109
    [Google Scholar]
  66. Wu P.-S., Chang L.-Y., Berkhout B., Hoek L., Lu C.-Y., Kao C.-L., Lee P.-I., Shao P.-L., Lee C.-Y. et al. 2008; Clinical manifestations of human coronavirus NL63 infection in children in Taiwan. Eur J Pediatr 167:75–80 [CrossRef][PubMed]
    [Google Scholar]
  67. Zhang L., Peeples M. E., Boucher R. C., Collins P. L., Pickles R. J. 2002; Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 76:5654–5666 [CrossRef][PubMed]
    [Google Scholar]
  68. Zhang L., Bukreyev A., Thompson C. I., Watson B., Peeples M. E., Collins P. L., Pickles R. J. 2005; Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol 79:1113–1124 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.028381-0
Loading
/content/journal/jgv/10.1099/vir.0.028381-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error